Good morning :)
$
₹
Tekla Healthcare Investors

Tekla Healthcare Investors

HQH

NYSE
Asset Logo

Tekla Healthcare Investors

HQH

NYSE
$21.740.01% (-0.00)
$
₹
$21.740.01% (-0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Financial Services

Asset Management

Small Cap

With a market cap of $1.3B the stock is ranked 2582

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

5.03
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.13
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$4.44
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

4561.32%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

10%

Company Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Peers

Peers

BlackRock Inc
BLK
BlackRock Inc
P/E Ratio
26.24
26.24
1Y Return
4.8%
4.8%
Buy Reco %
94.11
94.11
Blackstone Group Inc
BX
Blackstone Group Inc
P/E Ratio
29.94
29.94
1Y Return
29.5%
29.5%
Buy Reco %
43.47
43.47
KKR & Co. Inc.
KKR
KKR & Co. Inc.
P/E Ratio
33.79
33.79
1Y Return
30.18%
30.18%
Buy Reco %
95.23
95.23
Brookfield Corp
BN
B
P/E Ratio
71.79
71.79
1Y Return
16.63%
16.63%
Buy Reco %
90.90
90.90
Apollo Global Management LLC Class A
APO
Apollo Global Management LLC Class A
P/E Ratio
46.94
46.94
1Y Return
5.06%
5.06%
Buy Reco %
78.94
78.94

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
Financial ServicesAsset Management

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Tekla Healthcare Investors 5.031.130
BlackRock Inc26.242.940.91
Blackstone Group Inc29.9411.151.25

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

5.4
85.2
17
173.4
Q4 2024
Q1 2025
Q3 2025
Q1 2026
Revenue
Net Income
Financial YearQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q3 2025Q1 2026
Total Revenue5.6275.234.662.655.305.465.46-17.02-
Net Income83.16-26.82-26.8249.8499.6985.2485.24-173.44-
Net Profit Margin1477.71%-35.65%-575.22%1879.20%1879.20%1560.20%1560.20%-1018.49%-
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Tekla Healthcare Investors (HQH) share price today is $21.74 as of September 12, 2026 at 1:30 AM IST. The stock touched a day high of $22.05 and a day low of $21.74.

  2. Tekla Healthcare Investors stock trades on NYSE under the ticker symbol HQH.

  3. Tekla Healthcare Investors's market capitalization is $1.28B as of September 12, 2026 at 1:30 AM IST.

  4. Tekla Healthcare Investors's price-to-earnings (P/E) ratio is 5.03 as of September 11, 2026.

  5. Tekla Healthcare Investors's price-to-book (P/B) ratio is 1.13 as of September 11, 2026.

  6. Yes, Tekla Healthcare Investors pays a dividend, with a current dividend yield of 10%.

  7. Yes, You can buy Tekla Healthcare Investors shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Tekla Healthcare Investors shares in three steps: 1. Search Tekla Healthcare Investors on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Tekla Healthcare Investors trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Tekla Healthcare Investors (HQH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4598 shares at the current price of $21.74.

Loading...